EED inhibitor-1 |
| Catalog No.GC32909 |
L'inhibiteur EED-1 est un inhibiteur du développement de l'ectoderme embryonnaire (EED) extrait du brevet US20160176882 A1, exemple composé 2. L'inhibiteur EED-1 présente des IC50 de 59, 89, 26 nM dans la liaison EED Alphascreen, LC-MS et ELISA.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1951408-58-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
EED inhibitor-1 is an EED inhibitor extracted from patent US20160176882 A1, compound example 2; has IC50s of 59, 89, 26 nM in EED Alphascreen binding, LC-MS and ELISA assay.
EED inhibitor-1 has antiproliferative activities in B cell lymphoma cell KARPAS422 after 14 days of treatment with an IC50 of 30 nM[1].
[1]. US20160176882 A1
Average Rating: 5 (Based on Reviews and 27 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *